The Company continuously modernizes its governance structure and refines its decision-making mechanisms, laying a solid foundation for more efficient strategy implementation. Furthermore, it strengthens its capabilities to anticipate and mitigate various operational risks, while embedding business ethics into both operational practices and employee mindset. Additionally , by upholding Party leadership, the Company leverages it as an enduring driving force and fundamental guarantee for high-quality development.

n Our Commitments

Ø Establish a modern governance framework with clear rights and responsibilities.

Ø Fortify a compliance and risk control defense line with comprehensive coverage.

Ø Cultivate a diversified communication mechanism characterized by sunshine and transparency.

n Our Actions

Ø Robust Corporate Governance：In 2025, to further optimize governance efficiency and strengthen the overall planning of professional supervision, the Company performed legal decision-making procedures to adjust its governance structure, disbanding its Supervisory Committee, whose statutory powers and functions as stipulated under the Company Law were transferred to the Audit Committee of the Board for exercise. Simultaneously, the Company revised and filed the Articles of Association, and fulfilled necessary obligations for information disclosure, consolidating the legality and standardization of structural adjustments.

Ø Board diversity：GYBYS is dedicated to improving board independence and diversity. The fruition has come with the revision of the Diversification Policy for the Board Members, which guarantees objective, professional and comprehensive governance decisions. The professional backgrounds and educational qualifications of board members cover core areas such as business management, strategic planning, finance and accounting, the pharmaceutical industry, and compliance and internal control. The expertise in each area complements the others effectively, supporting the professionalism and comprehensiveness of the Board's decision-making.

Ø Enhanced Due Diligence：To refine management of major economic contracts, the responsible department shall collaborate with other departments or introduce third-party institutions to carry out due diligence as appropriate. During the term of the contract, any change or termination must undergo a joint risk assessment by multiple departments to ensure that the risks to major business sections are kept under control throughout the process.

Ø Uphold Ethical Bottom Lines：GYBYS is committed to business ethics management according to the highest standards. Systematically advance initiatives against commercial bribery, corruption, and unfair competition. With efforts in systematic prevention , targeted supervision and long-term governance, we have built a high wall across the board against corruption risks. The Company has significantly improved its operation compliance performance through optimizing systems, perfecting structures, reinforcing implementation and promoting compliance culture, contributing to high-quality development.

n Our Performance

Ø 19 training sessions on corporate governance of listed companies held for Board members, with a total of 85 participants.

Ø GYBYS conducted self-examinations for common issues of its internal risk control systems, identifying and rectifying 11 issues.

Ø 100% legal review (compliance review) rate for major decisions, regulations and contracts.

Ø In 2025, a total of 58 training attendances were recorded for directors, totaling 214 training hours. A total of 9,334 training attendances were recorded for employees as well, totaling 22,750 training hours.

n Our Stories

         "I Am a Shareholder" Site Visit to GYBYS                            Subsidiaries organized online court hearing observation sessions.